JM
Josh Mesfin
Postdoctoral Scientist
Parabolis
MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas
JM
Josh Mesfin
Postdoctoral Scientist
Parabolis
Work experience
Postdoctoral Scientist
Top industry applications
Not enough data yet.
Results may appear later and can be imperfect.
Open to opportunities in
BioinformaticsCardiovascularImmunohistochemistryMicrofluidicsMolecular MedicineNanomaterials
Last updated Mar 2025
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.